Next Article in Journal
Pharmacologic Management of Monogenic and Very Early Onset Inflammatory Bowel Diseases
Next Article in Special Issue
BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSALR Mice
Previous Article in Journal
Dose-Effect Determination of a Neuroprotector Fraction Standardized in Coumarins of Tagetes lucida and Bioavailability
Previous Article in Special Issue
Recent Trends in Antisense Therapies for Duchenne Muscular Dystrophy
 
 
Article

Article Versions Notes

Pharmaceutics 2023, 15(3), 968; https://doi.org/10.3390/pharmaceutics15030968
Action Date Notes Link
article xml file uploaded 17 March 2023 07:57 CET Original file -
article xml uploaded. 17 March 2023 07:57 CET Update https://www.mdpi.com/1999-4923/15/3/968/xml
article pdf uploaded. 17 March 2023 07:57 CET Version of Record https://www.mdpi.com/1999-4923/15/3/968/pdf
article supplementary file uploaded. 17 March 2023 07:57 CET - https://www.mdpi.com/1999-4923/15/3/968#supplementary
article html file updated 17 March 2023 07:59 CET Original file -
article html file updated 6 April 2023 20:24 CEST Update https://www.mdpi.com/1999-4923/15/3/968/html
Back to TopTop